特拉匹韋(VX-950)，銷售的品牌名稱Incivek和incivo之下，是丙型肝炎由Vertex制藥和約翰遜&約翰遜開發(fā)的治療藥物。它是一類被稱為蛋白酶抑制劑的抗病毒藥物的成員。具體而言，泰拉普雷抑制丙型肝炎病毒酶NS3/4A絲氨酸蛋白酶。特拉匹韋僅適用于對(duì)基因1型丙型肝炎病毒感染和未被證明有效果或安全時(shí)，用于其他基因型病毒。聚乙二醇化干擾素和利巴韋林的標(biāo)準(zhǔn)治療對(duì)基因型1的效果較低。
(S)-Methyl 2-amino-3,3-dimethylbutanoate
(3S)-3-Amino-2-hydroxyhexanoic acid
(S)-2-Aminopentan-1-ol
(S)-2-((S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoic acid
(S)-2-(((Benzyloxy)carbonyl)amino)-3,3-dimethylbutanoic acid
(1S,3aR,6aS)-2-((S)-2-((S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid
(S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetic acid
(1S,3aR,6aS)-tert-Butyl octahydrocyclopenta[c]pyrrole-1-carboxylate
tert-Butyl 2-(2-(2-amino-2-cyclohexylacetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylate
(2S,3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride
(2S)-Methyl 2-(2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate
(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide
(1S,3aR,6aS)-Ethyl octahydrocyclopenta[c]pyrrole-1-carboxylate
